{
    "2018-12-20": [
        [
            {
                "time": "",
                "original_text": "【国信医药丨药店行业快评】外延成本下降，超跌构成机遇",
                "features": {
                    "keywords": [
                        "外延成本",
                        "下降",
                        "超跌",
                        "机遇"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "药店"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业事件点评:严厉打击欺诈骗保行为预计对药房业绩影响有限",
                "features": {
                    "keywords": [
                        "严厉",
                        "打击",
                        "欺诈",
                        "骗保",
                        "药房",
                        "业绩",
                        "影响有限"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物",
                        "药房"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}